We further show that a similar CD4+ T cell population can be found in progressively growing tumours in mice as they become insensitive to anti-PD1 therapy and in human patients with cancer who respond poorly to immune checkpoint therapy (ICT) and cancer vaccines. This evidence concerns the gene PDCD1 and neoplasm.